Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,690 | 2,700 | 2,620 | 4,610 | 120 |
| Marketable Securities | 1,610 | 2,580 | 2,000 | 400 | 1,370 |
| Receivables | 70 | 60 | 100 | 90 | 60 |
| Inventories | 220 | 150 | 0 | 0 | 0 |
| Other current assets | 200 | 170 | 30 | 20 | 30 |
| TOTAL | $3,790 | $5,660 | $4,750 | $5,120 | $1,580 |
| Non-Current Assets | |||||
| Investments And Advances | 2,330 | 50 | 0 | 0 | 0 |
| Other Non-Current Assets | 4,880 | 4,800 | 2,450 | 2,450 | 2,450 |
| TOTAL | $7,210 | $4,850 | $2,450 | $2,450 | $2,450 |
| Total Assets | $11,080 | $10,590 | $7,240 | $7,610 | $4,070 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 740 | 440 | 130 | 100 | 80 |
| Other current liabilities | 900 | 840 | 600 | 640 | 540 |
| TOTAL | $1,640 | $1,290 | $740 | $750 | $620 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 10 | 10 | 0 | 0 | 0 |
| TOTAL | $10 | $10 | $N/A | $N/A | $N/A |
| Total Liabilities | $1,660 | $1,300 | $740 | $750 | $620 |
| Shareholders' Equity | |||||
| Common Shares | 5,990 | 5,980 | 5,770 | 5,770 | 5,330 |
| Retained earnings | -143,560 | -143,590 | -144,020 | -143,600 | -143,270 |
| Other shareholders' equity | 1,520 | 1,500 | 10 | 0 | 0 |
| TOTAL | $9,420 | $9,290 | $6,500 | $6,860 | $3,440 |
| Total Liabilities And Equity | $11,080 | $10,590 | $7,240 | $7,610 | $4,060 |